Literature DB >> 10537309

Structure-function studies of the BTB/POZ transcriptional repression domain from the promyelocytic leukemia zinc finger oncoprotein.

X Li1, H Peng, D C Schultz, J M Lopez-Guisa, F J Rauscher, R Marmorstein.   

Abstract

The evolutionarily conserved BTB/POZ domain from the promyelocytic leukemia zinc finger (PLZF) oncoprotein mediates transcriptional repression through the recruitment of corepressor proteins containing histone deacetylases in acute promyelocytic leukemia. We have determined the 2.0 A crystal structure of the BTB/POZ domain from PLZF (PLZF-BTB/POZ), and have carried out biochemical analysis of PLZF-BTB/POZ harboring site-directed mutations to probe structure-function relationships. The structure reveals a novel alpha/beta homodimeric fold in which dimer interactions occur along two surfaces of the protein subunits. The conservation of BTB/POZ domain residues at the core of the protomers and at the dimer interface implies an analogous fold and dimerization mode for BTB/POZ domains from otherwise functionally unrelated proteins. Unexpectedly, the BTB/POZ domain forms dimer-dimer interactions in the crystals, suggesting a mode for higher-order protein oligomerization for BTB/POZ-mediated transcriptional repression. Biochemical characterization of PLZF-BTB/POZ harboring mutations in conserved residues involved in protein dimerization reveals that the integrity of the dimer interface is exquisitely sensitive to mutation and that dimer formation is required for wild-type levels of transcriptional repression. Interestingly, similar mutational analysis of residues within a pronounced protein cleft along the dimer interface, which had been implicated previously for interaction with corepressors, has negligible effects on dimerization or transcriptional repression. Together, these studies form a structure-function framework for understanding BTB/POZ-mediated oligomerization and transcriptional repression properties.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10537309

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  35 in total

1.  NAC-1 is a brain POZ/BTB protein that can prevent cocaine-induced sensitization in the rat.

Authors:  S A Mackler; L Korutla; X Y Cha; M J Koebbe; K M Fournier; M S Bowers; P W Kalivas
Journal:  J Neurosci       Date:  2000-08-15       Impact factor: 6.167

Review 2.  All in the family: the BTB/POZ, KRAB, and SCAN domains.

Authors:  T Collins; J R Stone; A J Williams
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

3.  In-depth mutational analysis of the promyelocytic leukemia zinc finger BTB/POZ domain reveals motifs and residues required for biological and transcriptional functions.

Authors:  A Melnick; K F Ahmad; S Arai; A Polinger; H Ball; K L Borden; G W Carlile; G G Prive; J D Licht
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

4.  Functional studies of the BTB domain in the Drosophila GAGA and Mod(mdg4) proteins.

Authors:  D Read; M J Butte; A F Dernburg; M Frasch; T B Kornberg
Journal:  Nucleic Acids Res       Date:  2000-10-15       Impact factor: 16.971

5.  Phyllopod acts as an adaptor protein to link the sina ubiquitin ligase to the substrate protein tramtrack.

Authors:  Songhui Li; Chunyan Xu; Richard W Carthew
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

6.  Structure of the wild-type human BCL6 POZ domain.

Authors:  Mark A Stead; Gareth O Rosbrook; Jonathan M Hadden; Chi H Trinh; Stephen B Carr; Stephanie C Wright
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2008-11-28

7.  Structure of the human Nac1 POZ domain.

Authors:  Mark A Stead; Stephen B Carr; Stephanie C Wright
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2009-04-24

8.  Structures of heterodimeric POZ domains of Miz1/BCL6 and Miz1/NAC1.

Authors:  Mark Alexander Stead; Stephanie Claire Wright
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2014-11-14       Impact factor: 1.056

9.  Cloning and characterization of a novel druggable fusion kinase in acute myeloid leukemia.

Authors:  Christian Michel; Elisabeth K.M. Mack; Christopher-Nils Mais; Lea V Fritz; Ying Wang; Lutz B. Jehn; Sonja K. Hühn; Clara Simon; Sabrina Inselmann; André Marquardt; Jennifer Kremer; Ellen Wollmer; Kristina Sohlbach; Andreas Neubauer; Cornelia A. Brendel; Claudia Haferlach; Gert Bange; Andreas Burchert
Journal:  Haematologica       Date:  2019-12-02       Impact factor: 9.941

10.  The Drosophila transcription factor tramtrack (TTK) interacts with Trithorax-like (GAGA) and represses GAGA-mediated activation.

Authors:  Sara Pagans; Miguel Ortiz-Lombardía; Ma Lluïsa Espinás; Jordi Bernués; Fernando Azorín
Journal:  Nucleic Acids Res       Date:  2002-10-15       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.